{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:57:50Z","timestamp":1768013870950,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,9,12]],"date-time":"2015-09-12T00:00:00Z","timestamp":1442016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"BRAHMS GmbH, Germany"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s00408-015-9802-y","type":"journal-article","created":{"date-parts":[[2015,9,12]],"date-time":"2015-09-12T06:53:51Z","timestamp":1442040831000},"page":"901-910","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PH"],"prefix":"10.1007","volume":"193","author":[{"given":"Martin","family":"Kolditz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-J\u00fcrgen","family":"Seyfarth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinrike","family":"Wilkens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Ewert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Bollmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Dinter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Hertel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Klose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Opitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekkehard","family":"Gr\u00fcnig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert","family":"H\u00f6ffken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Halank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,12]]},"reference":[{"issue":"62","key":"9802_CR1","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","volume":"24","author":"G Simonneau","year":"2013","unstructured":"Simonneau G, Gatzoulis MA, Adatia I et al (2013) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 24(62):D34\u2013D41","journal-title":"J Am Coll Cardiol"},{"key":"9802_CR2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","volume":"142","author":"RL Benza","year":"2012","unstructured":"Benza RL, Miller DP, Barst RJ, Badesch DB, Frost AE, McGoon MD (2012) An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. Chest 142:448\u2013456","journal-title":"Chest"},{"issue":"62","key":"9802_CR3","doi-asserted-by":"crossref","first-page":"D92","DOI":"10.1016\/j.jacc.2013.10.024","volume":"24","author":"NH Kim","year":"2013","unstructured":"Kim NH, Delcroix M, Jenkins DP et al (2013) Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol 24(62):D92\u2013D99","journal-title":"J Am Coll Cardiol"},{"issue":"124","key":"9802_CR4","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.110.015008","volume":"1","author":"J Pepke-Zaba","year":"2011","unstructured":"Pepke-Zaba J, Delcroix M, Lang I et al (2011) Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 1(124):1973\u20131981","journal-title":"Circulation"},{"key":"9802_CR5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1378\/chest.103.3.685","volume":"103","author":"KM Moser","year":"1993","unstructured":"Moser KM, Bloor CM (1993) Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest 103:685\u2013692","journal-title":"Chest"},{"key":"9802_CR6","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1253\/circj.70.1058","volume":"70","author":"HJ Reesink","year":"2006","unstructured":"Reesink HJ, Meijer RC, Lutter R et al (2006) Hemodynamic and clinical correlates of endothelin-1 in chronic thromboembolic pulmonary hypertension. Circ J 70:1058\u20131063","journal-title":"Circ J"},{"key":"9802_CR7","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1378\/chest.120.5.1562","volume":"120","author":"C Rubens","year":"2001","unstructured":"Rubens C, Ewert R, Halank M et al (2001) Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest 120:1562\u20131569","journal-title":"Chest"},{"key":"9802_CR8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1465-9921-14-104","volume":"14","author":"D Harzheim","year":"2013","unstructured":"Harzheim D, Klose H, Pinado FP et al (2013) Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Respir Res 14:104","journal-title":"Respir Res"},{"key":"9802_CR9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00408-013-9472-6","volume":"191","author":"M Halank","year":"2013","unstructured":"Halank M, Einsle F, Lehman S et al (2013) Exercise capacity affects quality of life in patients with pulmonary hypertension. Lung 191:337\u2013343","journal-title":"Lung"},{"issue":"62","key":"9802_CR10","doi-asserted-by":"crossref","first-page":"D73","DOI":"10.1016\/j.jacc.2013.10.034","volume":"24","author":"VV McLaughlin","year":"2013","unstructured":"McLaughlin VV, Gaine SP, Howard LS et al (2013) Treatment goals of pulmonary hypertension. J Am Coll Cardiol 24(62):D73\u2013D81","journal-title":"J Am Coll Cardiol"},{"issue":"369","key":"9802_CR11","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","volume":"25","author":"HA Ghofrani","year":"2013","unstructured":"Ghofrani HA, Galie N, Grimminger F et al (2013) Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med 25(369):330\u2013340","journal-title":"N Engl J Med"},{"issue":"369","key":"9802_CR12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1209657","volume":"25","author":"HA Ghofrani","year":"2013","unstructured":"Ghofrani HA, D\u2019Armini AM, Grimminger F et al (2013) Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med 25(369):319\u2013329","journal-title":"N Engl J Med"},{"key":"9802_CR13","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1378\/chest.06-1758","volume":"131","author":"HH Leuchte","year":"2007","unstructured":"Leuchte HH, El NM, Tuerpe JC et al (2007) N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension. Chest 131:402\u2013409","journal-title":"Chest"},{"key":"9802_CR14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1465-9921-14-130","volume":"14","author":"NP Nickel","year":"2013","unstructured":"Nickel NP, Lichtinghagen R, Golpon H et al (2013) Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertension. Respir Res 14:130","journal-title":"Respir Res"},{"issue":"55","key":"9802_CR15","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.jacc.2010.02.025","volume":"11","author":"A Maisel","year":"2010","unstructured":"Maisel A, Mueller C, Nowak R et al (2010) Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 11(55):2062\u20132076","journal-title":"J Am Coll Cardiol"},{"issue":"49","key":"9802_CR16","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.jacc.2006.12.038","volume":"10","author":"SQ Khan","year":"2007","unstructured":"Khan SQ, O\u2019Brien RJ, Struck J et al (2007) Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol 10(49):1525\u20131532","journal-title":"J Am Coll Cardiol"},{"issue":"182","key":"9802_CR17","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1164\/rccm.201003-0415OC","volume":"1","author":"S Kruger","year":"2010","unstructured":"Kruger S, Ewig S, Giersdorf S, Hartmann O, Suttorp N, Welte T (2010) Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: results from the German Competence Network, CAPNETZ. Am J Respir Crit Care Med 1(182):1426\u20131434","journal-title":"Am J Respir Crit Care Med"},{"issue":"54","key":"9802_CR18","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jacc.2009.04.011","volume":"30","author":"DB Badesch","year":"2009","unstructured":"Badesch DB, Champion HC, Sanchez MA et al (2009) Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 30(54):S55\u2013S66","journal-title":"J Am Coll Cardiol"},{"key":"9802_CR19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","volume":"166","author":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratorie","year":"2002","unstructured":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratorie (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111\u2013117","journal-title":"Am J Respir Crit Care Med"},{"issue":"106","key":"9802_CR20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/01.CIR.0000022687.18568.2A","volume":"16","author":"R Wensel","year":"2002","unstructured":"Wensel R, Opitz CF, Anker SD et al (2002) Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation 16(106):319\u2013324","journal-title":"Circulation"},{"key":"9802_CR21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.clinbiochem.2010.12.012","volume":"44","author":"D Miguel","year":"2011","unstructured":"Miguel D, Prieto B, Costa M, Coto D, Alvarez FV (2011) Cord blood plasma reference intervals for potential sepsis markers: pro-adrenomedullin, pro-endothelin, and pro-atrial natriuretic peptide. Clin Biochem 44:337\u2013341","journal-title":"Clin Biochem"},{"key":"9802_CR22","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.clinbiochem.2009.01.002","volume":"42","author":"P Caruhel","year":"2009","unstructured":"Caruhel P, Mazier C, Kunde J, Morgenthaler NG, Darbouret B (2009) Homogeneous time-resolved fluoroimmunoassay for the measurement of midregional proadrenomedullin in plasma on the fully automated system B.R.A.H.M.S KRYPTOR. Clin Biochem 42:725\u2013728","journal-title":"Clin Biochem"},{"key":"9802_CR23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/1874241601205010021","volume":"5","author":"D Terzic","year":"2012","unstructured":"Terzic D, Johansson-F\u00e4llgren AS, Ragnarsson O, Goetze JP, Hammarsten O (2012) Evaluation of a sensitive copeptin assay for clinical measurement. Open Clin Chem J 5:21\u201326","journal-title":"Open Clin Chem J"},{"key":"9802_CR24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1515\/CCLM.2004.008","volume":"42","author":"C Prontera","year":"2004","unstructured":"Prontera C, Emdin M, Zucchelli GC, Ripoli A, Passino C, Clerico A (2004) Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide. Clin Chem Lab Med 42:37\u201344","journal-title":"Clin Chem Lab Med"},{"key":"9802_CR25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","volume":"56","author":"PJ Heagerty","year":"2000","unstructured":"Heagerty PJ, Lumley T, Pepe MS (2000) Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56:337\u2013344","journal-title":"Biometrics"},{"issue":"Suppl 1","key":"9802_CR26","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1111\/j.1751-7133.2010.00177.x","volume":"16","author":"NG Morgenthaler","year":"2010","unstructured":"Morgenthaler NG (2010) Copeptin: a biomarker of cardiovascular and renal function. Congest Heart Fail 16(Suppl 1):S37\u2013S44","journal-title":"Congest Heart Fail"},{"key":"9802_CR27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1373\/clinchem.2003.021204","volume":"50","author":"NG Morgenthaler","year":"2004","unstructured":"Morgenthaler NG, Struck J, Thomas B, Bergmann A (2004) Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. Clin Chem 50:234\u2013236","journal-title":"Clin Chem"},{"key":"9802_CR28","first-page":"167","volume":"51","author":"G Hess","year":"2005","unstructured":"Hess G, Runkel S, Zdunek D, Hitzler WE (2005) N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease. Clin Lab 51:167\u2013172","journal-title":"Clin Lab"},{"issue":"40","key":"9802_CR29","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(02)02012-0","volume":"21","author":"O Sitbon","year":"2002","unstructured":"Sitbon O, Humbert M, Nunes H et al (2002) Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 21(40):780\u2013788","journal-title":"J Am Coll Cardiol"},{"issue":"122","key":"9802_CR30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","volume":"13","author":"RL Benza","year":"2010","unstructured":"Benza RL, Miller DP, Gomberg-Maitland M et al (2010) Predicting survival in pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL). Circulation 13(122):164\u2013172","journal-title":"Circulation"},{"issue":"60","key":"9802_CR31","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jacc.2012.01.083","volume":"25","author":"G Savarese","year":"2012","unstructured":"Savarese G, Paolillo S, Costanzo P et al (2012) Do changes of 6-minute walk distance predict clinical events in patients with pulmonary arterial hypertension? A meta-analysis of 22 randomized trials. J Am Coll Cardiol 25(60):1192\u20131201","journal-title":"J Am Coll Cardiol"},{"key":"9802_CR32","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1183\/09031936.00217911","volume":"40","author":"G DeBoeck","year":"2012","unstructured":"DeBoeck G, Scoditti C, Huez S et al (2012) Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension. Eur Respir J 40:1410\u20131419","journal-title":"Eur Respir J"},{"key":"9802_CR33","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1249\/MSS.0b013e31817c92c0","volume":"40","author":"H Groepenhoff","year":"2008","unstructured":"Groepenhoff H, Vonk-Noordegraaf A, Boonstra A, Spreeuwenberg MD, Postmus PE, Bogaard HJ (2008) Exercise testing to estimate survival in pulmonary hypertension. Med Sci Sports Exerc 40:1725\u20131732","journal-title":"Med Sci Sports Exerc"},{"issue":"167","key":"9802_CR34","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.ijcard.2012.03.135","volume":"20","author":"R Wensel","year":"2013","unstructured":"Wensel R, Francis DP, Meyer FJ et al (2013) Incremental prognostic value of cardiopulmonary exercise testing and resting haemodynamics in pulmonary arterial hypertension. Int J Cardiol 20(167):1193\u20131198","journal-title":"Int J Cardiol"},{"issue":"324","key":"9802_CR35","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1136\/bmj.324.7352.1498","volume":"22","author":"FD Hobbs","year":"2002","unstructured":"Hobbs FD, Davis RC, Roalfe AK, Hare R, Davies MK, Kenkre JE (2002) Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ 22(324):1498","journal-title":"BMJ"},{"key":"9802_CR36","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/0735-1097(95)00399-1","volume":"26","author":"M Nootens","year":"1995","unstructured":"Nootens M, Kaufmann E, Rector T et al (1995) Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. J Am Coll Cardiol 26:1581\u20131585","journal-title":"J Am Coll Cardiol"},{"key":"9802_CR37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/187221412799015263","volume":"6","author":"BM Cheung","year":"2012","unstructured":"Cheung BM, Tang F (2012) Adrenomedullin: exciting new horizons. Recent Pat Endocr Metab Immune Drug Discov 6:4\u201317","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"9802_CR38","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1378\/chest.13-1967","volume":"146","author":"D Stolz","year":"2014","unstructured":"Stolz D, Boersma W, Blasi F et al (2014) Exertional hypoxemia in stable COPD is common and predicted by circulating proadrenomedullin. Chest 146:328\u2013338","journal-title":"Chest"},{"key":"9802_CR39","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejogrb.2010.10.013","volume":"154","author":"E Marinoni","year":"2011","unstructured":"Marinoni E, Pacioni K, Sambuchini A, Moscarini M, Letizia C, DI Iorio R (2011) Regulation by hypoxia of adrenomedullin output and expression in human trophoblast cells. Eur J Obstet Gynecol Reprod Biol 154:146\u2013150","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"63","key":"9802_CR40","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.jacc.2013.12.034","volume":"29","author":"RG O\u2019Malley","year":"2014","unstructured":"O\u2019Malley RG, Bonaca MP, Scirica BM et al (2014) Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36). J Am Coll Cardiol 29(63):1644\u20131653","journal-title":"J Am Coll Cardiol"},{"key":"9802_CR41","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.thromres.2013.08.008","volume":"132","author":"J Pedowska-Wloszek","year":"2013","unstructured":"Pedowska-Wloszek J, Kostrubiec M, Kurnicka K, Ciurzynski M, Palczewski P, Pruszczyk P (2013) Midregional proadrenomedullin (MR-proADM) in the risk stratification of patients with acute pulmonary embolism. Thromb Res 132:506\u2013510","journal-title":"Thromb Res"},{"key":"9802_CR42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1183\/09031936.00058713","volume":"43","author":"D Stolz","year":"2014","unstructured":"Stolz D, Kostikas K, Blasi F et al (2014) Adrenomedullin refines mortality prediction by the BODE index in COPD: the \u201cBODE-A\u201d index. Eur Respir J 43:397\u2013408","journal-title":"Eur Respir J"},{"key":"9802_CR43","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.08-0047","volume":"134","author":"D Stolz","year":"2008","unstructured":"Stolz D, Christ-Crain M, Morgenthaler NG et al (2008) Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD. Chest 134:263\u2013272","journal-title":"Chest"},{"key":"9802_CR44","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ejhf.158","volume":"16","author":"R Kaiser","year":"2014","unstructured":"Kaiser R, Abdul-Khaliq H, Wilkens H, Herrmann E, Raedle-Hurst TM (2014) Mid-regional pro-adrenomedullin: an indicator of the failing Fontan circuit in patients with univentricular hearts? Eur J Heart Fail 16:1082\u20131088","journal-title":"Eur J Heart Fail"},{"key":"9802_CR45","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1183\/09031936.00104412","volume":"41","author":"M Kolditz","year":"2013","unstructured":"Kolditz M, Ewig S, Hoffken G (2013) Management-based risk prediction in community-acquired pneumonia by scores and biomarkers. Eur Respir J 41:974\u2013984","journal-title":"Eur Respir J"},{"key":"9802_CR46","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1471-2334-11-112","volume":"11","author":"WC Albrich","year":"2011","unstructured":"Albrich WC, Dusemund F, Ruegger K et al (2011) Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm. BMC Infect Dis 11:112","journal-title":"BMC Infect Dis"},{"key":"9802_CR47","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1183\/09031936.00113612","volume":"42","author":"WC Albrich","year":"2013","unstructured":"Albrich WC, Ruegger K, Dusemund F et al (2013) Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial. Eur Respir J 42:1064\u20131075","journal-title":"Eur Respir J"},{"key":"9802_CR48","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.healun.2013.06.020","volume":"32","author":"MJ Silva","year":"2013","unstructured":"Silva MJ, Martins SR, Calisto C et al (2013) An exploratory panel of biomarkers for risk prediction in pulmonary hypertension: emerging role of CT-proET-1. J Heart Lung Transplant 32:1214\u20131221","journal-title":"J Heart Lung Transplant"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-015-9802-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-015-9802-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-015-9802-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T14:38:03Z","timestamp":1559054283000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-015-9802-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,12]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["9802"],"URL":"https:\/\/doi.org\/10.1007\/s00408-015-9802-y","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,12]]}}}